Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-12-12T17:33:32Z No. of bitstreams: 1 ThalyneYuriAraujoFarias_TESE.pdf: 909519 bytes, checksum: 9bbecdd157280cdc04c52bdc00e0a52b (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-12-13T17:47:53Z (GMT) No. of bitstreams: 1 ThalyneYuriAraujoFarias_TESE.pdf: 909519 bytes, checksum: 9bbecdd157280cdc04c52bdc00e0a52b (MD5) / Made available in DSpace on 2017-12-13T17:47:53Z (GMT). No. of bitstreams: 1 ThalyneYuriAraujoFarias_TESE.pdf: 909519 bytes, checksum: 9bbecdd157280cdc04c52bdc00e0a52b (MD5) Previous issue date: 2017-08-30 / A ?lcera venosa (UV) ? caracterizada pela perda irregular e circunscrita da derme e epiderme, podendo acometer tecidos subcut?neos e subjacentes. Sua causa est? relacionada a disfun??o do sistema vascular venoso. ? considerado um grande problema de sa?de p?blica, gerando impacto na economia, dor permanente, incapacidade de realiza??o das atividades de vida di?ria, problemas biopsicossociais, isolamento social, al?m da diminui??o da qualidade de vida. O estudo objetiva avaliar a qualidade de vida de pessoas com ?lcera venosa atrav?s do ChronIc Venous Insufficiency quality of life Questionnaire (CIVIQ-20). Estudo transversal, quantitativo, com amostra n?o probabil?stica, composta por 30 pessoas com doen?a venosa, que tinham ?lcera ativa com classifica??o cl?nica 6, realizado no ambulat?rio de angiologia de um hospital universit?rio em Natal Rio Grande do Norte, entre os meses de mar?o e novembro de 2016, atrav?s de um formul?rio estruturado de entrevista com caracter?sticas sociodemogr?ficas e de sa?de e um instrumento de Qualidade de Vida Relacionada ? Sa?de, CIVIQ-20. Predominaram nesse estudo pessoas acima de 60 anos (66,7%), do g?nero feminino (86,7%), solteira vi?va ou divorciadas (66,7%), baixa escolaridade (83,3%). 40% tinha hist?ria familiar de doen?a venosa, 80% passaram por gesta??es, 76,7% apresentavam veias varicosas e 70% tinham hipertens?o arterial. 73,3% apresentaram tempo de tratamento da UV maior que seis meses e 70,0% n?o tinham orienta??o para o uso de terapia compressiva. Todas as dimens?es do CIVIQ (F?sica, Dor, Social e Psicol?gica) e escore total do instrumento obtiveram m?dias e medianas com valores que se aproximam dos escores de pior qualidade de vida, com varia??es estatisticamente significantes (p<0,001), com destaque para a dimens?o f?sica com m?dia de 71,0 e dor com m?dia de 67,0. Ao correlacionar as dimens?es de qualidade de vida do CIVIQ entre elas, a correla??o foi de moderada a forte, com p- valor significante para todas as correla??es entre as dimens?es. Com destaque para a correla??o entre a dimens?o f?sica e dimens?o dor, assim como dimens?o f?sica com o escore total do instrumento. Conclus?o: Os resultados demonstram um importante impacto das dimens?es do instrumento na qualidade de vida dos portadores de DVC participantes deste estudo, com destaque para a dor e dimens?o f?sica. / Venous ulcer is characterized by irregular and circumscribed loss of the dermis and epidermis, which can affect subcutaneous and underlying tissues. Its cause is related to dysfunction of the venous vascular system. It is considered a major public health problem, generating an impact on the economy, permanent pain, inability to perform activities of daily living, biopsychosocial problems, social isolation, and a decrease in quality of life. The study aims to evaluate the quality of life of people with venous ulcer through ChronIc Venous Insufficiency quality of life Questionnaire (CIVIQ-20). A cross-sectional, quantitative, non-probabilistic sample composed of 30 people with venous disease who had active ulcer, Clinical APC 6, performed at the angiology outpatient clinic of a university hospital in Natal, Rio Grande do Norte between March and November 2016, through a structured interview form with sociodemographic and health characteristics and a Health Related Quality of Life instrument, CIVIQ-20. Prevalence in this study was over 60 years old (66.7%), female (86.7%), single widowed or divorced (66.7%), low educational level (83.3%). 40% had a family history of venous disease, 80% had gestations, 76.7% had varicose veins, and 70% had arterial hypertension. 73.3% had a VU treatment time greater than six months and 70.0% had no guidance for the use of compressive therapy. All the dimensions of the CIVIQ (Physical, Pain, Social and Psychological) and total score of the instrument obtained means and medians with values that approximate the scores of worse quality of life, with statistically significant variations (p<0.001), Physical dimension with a mean of 71.0 and Pain with a mean of 67.0. When correlating the quality of life dimensions of CIVIQ between them, the correlation was moderate to strong, with a significant p-value for all correlations between dimensions. With emphasis on the correlation between the physical dimension and pain dimension, as well as physical dimension with the total score of the instrument. Conclusion: The results show a major impact on the dimensions of the instrument in the quality of life of patients with CVD study participants, highlighting the pain and physical dimension. It is confirmed that the CIVIQ is an instrument of high reliability to verify the quality of life of people with venous disease.

Made available in DSpace on 2014-12-17T15:16:20Z (GMT). No. of bitstreams: 1 DiegoNA_DISSERT.pdf: 3427521 bytes, checksum: 8cca32583d3549111fe36c75cda96e2e (MD5) Previous issue date: 2014-02-04 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Venous wounds cause physical, psychological and financial problems that impact the quality of life of patients. Treatment alternatives are investigated in order to reduce healthcare costs and improve quality of life of people affected by this problem. Physical resources, such as therapeutic ultrasound (US), are being considered in the treatment of ulcers as a potential healing agent. This study aimed to investigate the application of US as a treatment for venous ulcers. Subjects were divided into two groups: US group, where treatment consisted of 5 sessions of pulsed US (3 MHz, 1W/cm?) associated with compression and kinesiotherapy; and sham group, where individuals went through the same procedures, but with sham US therapy. Subjects were evaluated for wound size by planimetry and digital photography, visual analogue scale for pain, quality of life by the questionnaires SF- 36 and VEINES-QoL/Sym and enzymatic activity of metalloproteinases 2 and 9 by zymography. It was observed mean reduction in wound area of 41.58?53.8% for the US group and 63.47?37.2% for the placebo group, maintenance of quality of life scores in the US group and significant improvement (p<0.05) in the placebo group by VEINES questionnaire. It was observed decreased perception of pain in the placebo group. Sample feasibility for analysis of the protein activity of metalloproteinases 2 and 9 by zymography collected by swab method was also confirmed. Our data did not give us evidence to support the theory that the US accelerates healing of venous ulcers in a short-term analysis. However, we observed that standard care associated with compression therapy and kinesiotherapy were able to significantly shorten the progression of chronic venous ulcers / As ?lceras cut?neas de origem venosa causam problemas f?sicos, psicol?gicos e financeiros que impactam a qualidade de vida dos pacientes. Alternativas de tratamento s?o investigadas no intuito de reduzir gastos com a sa?de e melhorar a qualidade de vida das pessoas acometidas com esse problema. Recursos f?sicos como o ultrassom (US) terap?utico vem sendo considerados no tratamento de ?lceras como potencial agente cicatrizador. O objetivo desse estudo foi investigar a aplica??o de US como terap?utica para a ?lcera venosa. Indiv?duos foram divididos em dois grupos: grupo US, onde o tratamento consistia de 5 sess?es de aplica??o de US pulsado (3 MHz, 1W/cm?) associadas ? terapia compressiva e cinesioterapia; e grupo placebo, onde os indiv?duos passavam pelos mesmos procedimentos, por?m com US placebo. Foram avaliados quanto ao tamanho do ferimento por planimetria e fotografia digital, dor por escala visual anal?gica, qualidade de vida pelos question?rios SF-36 e VEINES-QoL/Sym e atividade enzim?tica de metaloproteinases 2 e 9 por meio de zimografia. Foi observada redu??o m?dia da ?rea da ferida 41,58%?53,8 para o grupo US e 63,47%?37,2 para o grupo placebo, manuten??o dos escores de qualidade de vida no grupo US e melhora significativa (p<0,05) no grupo Placebo pelo question?rio VEINES. Observou-se diminui??o da percep??o de dor no grupo placebo. Confirmou-se viabilidade de amostra para an?lise da atividade proteica de metaloproteinases 2 e 9 por zimografia coletada por m?todo de swab. Diante dos dados, n?o obtivemos evid?ncias suficientes para suportar a teoria que o US acelera a cicatriza??o de ?lceras venosas em curto prazo. No entanto, pudemos observar que o tratamento padr?o associado ? terapia compressiva e ? cinesioterapia foram capazes de abreviar significativamente a progress?o das ?lceras venosas cr?nicas

Submitted by SBI Biblioteca Digital (sbi.bibliotecadigital@puc-campinas.edu.br) on 2017-04-12T13:04:38Z No. of bitstreams: 1 GUILHERME CAMARGO GON?ALVES DE ABREU.pdf: 3685278 bytes, checksum: b38c6f9cbee974306c1235fc31b386a3 (MD5) / Made available in DSpace on 2017-04-12T13:04:38Z (GMT). No. of bitstreams: 1 GUILHERME CAMARGO GON?ALVES DE ABREU.pdf: 3685278 bytes, checksum: b38c6f9cbee974306c1235fc31b386a3 (MD5) Previous issue date: 2017-02-22 / Chronic Venous Insufficiency (CVI) is the leading cause of venous leg ulcers (VLU). Primary varicose veins are the most frequent cause of CVI. The requirements for each treatment method limits its applicability. Foam sclerotherapy has been shown to be effective, safe and great applicability. OBJECTIVE: Analize patient?s evolution after ultrasound-guided foam sclerotherapy (USGFS). METHOD. Clinical trial without control group. Patients with primary CVI venous ulcer (VU) and great saphenous vein (GSV) reflux were treated with USGFS from June 2015 to June 2016. We evaluate diseases severity, quality of life (QoL), ulcer?s healing and elimination of venous reflux. Patients were followed for 180 days and evaluated by Doppler ultrasound (USD), Aberdeen varicose veins questionnaire (AVVQ) and venous clinical severity score (VCSS). Anatomical and clinical data were collected. AVVQ, VCSS and ulcers diameters were tested by ANOVA method. Patients were grouped according to outcome (VU healing, venous occlusion and reflux elimination) and variables were compared by the Mann-Whitney test or the Fisher exact test. RESULTS: 22 patients were treated (15 men and 7 women) aged 35 to 70 years (56 +/-10.5). There was improvement in quality of life, ulcers diameters antics were reduced (p < 0.001; ANOVA). 77% of VLU were completely healed, 14% remained open with reduced dimensions. Venous reflux was eliminated in 64% of the treated great saphenous vein. Worse QoL patients needed more treatment sessions (? = 0.5449; p = 0.0087; Spearman). Men had better QOL after 180 days and had a higher gain on QOL than women (p = 0.0074). Older patients, patients with larger ulcers, away from work and women had more severe disease (p 0.05 <; ANOVA). No variable related to evolution of clinical severity. Women had more complications (p = 0.017; Fisher) and there was no severe complications. Completely healed VLU and completely occluded GSV were at beginning smaller than not completely healed UV and not completely occluded GSV (p < 0.05; Mann-Whitney). CONCLUSION: The absence of severe adverse effects and improvement of evaluated parameters observed in most patients indicates that USGFS is an applicable alternative to patients with severe CVI. / A insufici?ncia venosa cr?nica (IVC) ? a principal causa de ?lceras nos membros inferiores (UV). Varizes prim?rias s?o a causa mais frequente de IVC. Os diversos tratamentos propostos para varizes com IVC apresentam requisitos que limitam sua aplicabilidade. Escleroterapia com espuma tem se mostrado eficaz segura barata e de grande aplicabilidade. OBJETIVO: Analisar a evolu??o dos portadores de IVC com refluxo da veia safena magna e ?lcera venosa submetidos a escleroterapia ecoguiada com espuma de polidocanol (EEE). M?TODO. Ensaio cl?nico sem grupo controle. Portadores de IVC prim?ria com ?lcera varicosa e refluxo na veia safena magna foram tratados com EEE de forma consecutiva. Os pacientes foram observados por 180 dias entre junho de 2015 e junho de 2016. A evolu??o dos pacientes foi estudada em termos de qualidade de vida (QV) avaliado pelo question?rio Aberdeen para veias varicosas (QA); gravidade da doen?a avaliada por escore de gravidade cl?nica (ECV), elimina??o do refluxo venoso pelo ultrassom Doppler (USD) e cicatriza??o de ?lceras. Foram coletados dados cl?nicos, anat?micos e sociais. QA, ECV, di?metro das ?lceras e a influ?ncia das vari?veis foram comparados pelo m?todo de ANOVA. Os pacientes foram agrupados de segundo desfecho (cicatriza??o de UV, oclus?o e elimina??o do refluxo venoso) e as vari?veis foram comparadas pelo teste de Mann-Whitney ou pelo teste exato de Fisher. RESULTADOS: Foram tratados 22 pacientes (7 homens e 15 mulheres) com idade entre 35 a 70 anos (56 +/- 10,5). Houve melhora na qualidade de vida, redu??o da gravidade da doen?a e redu??o dos di?metros das ?lceras (p<0.001; ANOVA). Houve cicatriza??o completa de 77% das UV, 14% permaneceram abertas com redu??o das dimens?es. Houve elimina??o do refluxo em 64% das VSM tratadas. Pacientes com pior QV necessitaram maior n?mero de sess?es para tratamento da doen?a (?=0.5449; p-valor = 0.0087; Spearman). Homens apresentaram melhor QV ap?s 180 dias e tiveram maior ganho na QV que as mulheres (p = 0.0074; Mann-Whitney). Pacientes mais idosos, portadores de ?lceras maiores, afastados do trabalho e mulheres (p<0,05; ANOVA) apresentaram doen?a mais grave. Nenhuma vari?vel se relacionou a evolu??o da gravidade cl?nica. Mulheres apresentaram mais complica??es (p = 0.017; Fisher) e n?o houve complica??es graves. As UV completamente cicatrizadas e as VSM que apresentaram oclus?o completa apresentavam dimens?es inicialmente menores quando comparadas as UV n?o completamente cicatrizadas e as VSM n?o completamente oclu?das (p<0,05; Mann-Whitney). CONCLUS?O: A aus?ncia de complica??es graves e a melhora observada dos par?metros avaliados na maioria dos pacientes indica que EEE ? alternativa aplic?vel aos portadores de IVC grave.

Made available in DSpace on 2014-12-17T15:16:20Z (GMT). No. of bitstreams: 1 CibeleTDR_DISSERT.pdf: 1600601 bytes, checksum: 17a20c970bdc4a9e7d51aa44c7922b20 (MD5) Previous issue date: 2014-02-04 / Chronic venous disease (CVD) is evident among the chronic diseases and affects the elderly population and primarily is responsible for leg ulcers in this population. The use of dressings in the care of a venous ulcer is a fundamental part of the treatment for healing, however, evidence to assist in choosing the best dressing is scarce. The main objective of this study was to evaluate the effectiveness of treatment with hydrogel in the healing of venous ulcers using search methods, synthesis of information and statistical research through a systematic review and meta-analysis. Randomized controlled trials were selected in the following databases: CENTRAL; DARE; NHS EED; MEDLINE; EMBASE; CINAHL. Beyond these databases three websites were consulted to identify ongoing studies: ClinicalTrials.gov, OMS ICTRP e ISRCTN. The primary outcomes were analyzed: complete wound healing, incidence of wound infection and the secondary were: changes in ulcer size, time to ulcer healing, recurrence of ulcer, quality of life of participants, pain and costs of treatment. Four studies are currently included in the review with a total of 250 participants. The use of hydrogel appears to be superior to conventional dressing, gauze soaked in saline, for the healing of venous leg ulcers; 16/30 patients showed complete healing of ulcers (RR 5,33, 95%CI [1,73,16,42]). The alginate gel was shown to be more effective when compared to the hydrogel dressing in reduction of the wound area; 61,2% (? 26,2%) with alginate e 19,4% (? 24,3%) with hydrogel at the end of four weeks of treatment. Manuka honey has shown to be similar to the hydrogel dressings in percentage of area reduction. This review demonstrated that there is no evidence available about the effectiveness of the hydrogel compared to other types of dressings on the healing of venous leg ulcers of the lower limbs, thus demonstrating the need of future studies to assist health professionals in choosing the correct dressing. / A doen?a venosa cr?nica (DVC) evidencia-se entre as doen?as cr?nicas por acometer a popula??o idosa e ser a principal respons?vel pelas ?lceras de membros inferiores nesta popula??o. O uso de adesivos no cuidado de uma ?lcera venosa ? parte fundamental no tratamento para a cicatriza??o, no entanto, as evid?ncias para auxiliar na escolha do melhor adesivo s?o escassas. O objetivo principal do estudo foi avaliar a efic?cia do tratamento com o hidrogel na cicatriza??o de ?lceras venosas mediante m?todos de busca, s?ntese de informa??o e an?lise estat?stica atrav?s de uma revis?o sistem?tica com meta-an?lise. Foram selecionados estudos controlados randomizados nas seguintes bases de dados: CENTRAL; DARE; NHS EED; MEDLINE; EMBASE; CINAHL. Al?m dessas bases foram consultados tr?s websites para identificar estudos em andamento: ClinicalTrials.gov, OMS ICTRP e ISRCTN. Os desfechos prim?rios analisados foram: cicatriza??o completa das ?lceras e incid?ncia de infec??o das ?lceras e os secund?rios foram: altera??es no tamanho da ?lcera, tempo de cicatriza??o das ?lceras, recorr?ncia das ?lceras, qualidade de vida dos participantes, dor e custos do tratamento. Quatro estudos est?o atualmente inclu?dos na revis?o com um total de 250 pacientes. O uso do hidrogel parece ser superior ao curativo convencional, gaze embebida em salina, para a cicatriza??o de ?lceras venosas de membros inferiores; 16/30 pacientes apresentaram cicatriza??o completa das ?lceras (RR 5,33, 95%CI [1,73,16,42]). O gel de alginato demonstrou ser mais efetivo quando comparado ao hidrogel quanto ? redu??o da ?rea da ?lcera; 61,2% (? 26,2%) com o alginato e 19,4% (? 24,3%) com o hidrogel ao final das quatro semanas de tratamento. O mel de Manuka demonstrou ser similar ao hidrogel em rela??o ? porcentagem de redu??o da ?rea. Esta revis?o mostrou que n?o existem evid?ncias dispon?veis a respeito da efic?cia do hidrogel em rela??o aos outros tipos de curativo na cicatriza??o de ?lceras venosas de membros inferiores, demonstrando assim a necessidade de futuras pesquisas para auxiliar os profissionais da sa?de na escolha do adesivo correto